Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AstraZeneca Unveils Nexium Direct-to-Patient Program

19th Mar 2014 12:34

LONDON (Alliance News) - AstraZeneca said it launched Nexium Direct, a program that provides eligible patients the option of having brand-name Nexium delivered directly to their home. Nexium Direct is part of AstraZeneca Direct, a web-based offering that delivers select brand name prescription medications from AstraZeneca directly to a person's home.

The company stated that the medications are dispensed by a team of registered pharmacists and certified pharmacy technicians available through a collaboration with Eagle Pharmacy, a trusted pharmacy partner.

According to the company, Enrollment in Nexium Direct is easy. There are no coupons or co-pay cards required; all a patient needs is a valid prescription from a physician. Patients simply go to www.purplepill.com and click on the Nexium Direct link to complete the online enrollment form and provide a valid prescription for Nexium. During and after enrollment, patients will have access to a 24-hour support center to contact via email or phone if they have questions, the opportunity to request auto refills, and free home delivery.

Copyright RTT News/dpa-AFX


Related Shares:

Astrazeneca
FTSE 100 Latest
Value8,413.68
Change-3.66